Navigation Links
New Rheumatoid Arthritis Treatment

A new study shows a novel new drug is beneficial for patients with rheumatoid arthritis. The drug targets T cells and is the first in a new class of drugs //to be tested for rheumatoid arthritis.

The drug is called cytotoxic T-lymphocyte-associated antigen 4-IgG1 or CTLA4Ig. Preliminary research shows CTLA4Ig may be effective for the treatment of rheumatoid arthritis. Researchers from Belgium conducted a study to see if this drug is helpful for patients with rheumatoid arthritis.

Rheumatoid arthritis is a disease that causes progressive joint damage and disability. For the study, researchers assigned patients to receive one of two doses of CTLA4Ig or placebo. All of the patients also received methotrexate therapy during the study. Researchers assessed the patients after six months using the criteria of the American College of Rheumatology (ACR). The ACR defines the response to the treatment according to its extent. A 20 percent clinical response rate is noted as ACR 20, 50 percent is ACR 50, and 70 percent is ACR 70. Researchers also looked at the patients’ quality of life.

Researchers report the patients treated with the higher dose of CTLA4Ig were more likely to have an ACR 20 than patients who received placebo. Higher rates of ACR 50 and ACR 70 were seen in both groups on the drug compared to placebo. The patients on the higher dose of the drug also saw improvements in eight measures of quality of life.

Study authors conclude the combination of CTLA4Ig and methotrexate improved the signs and symptoms of the disease, physical function, and quality of life in patients with rheumatoid arthritis. Researchers also say both doses of the drug were well tolerated by the patients. They say this study shows the value of this new class of drugs in the treatment of rheumatoid arthritis.
'"/>




Page: 1

Related medicine news :

1. New treatment for Rheumatoid Arthritis
2. New Rheumatoid Arthritis Treatment
3. Consumption Of Red Meat Found To Double The Risk of Rheumatoid Arthritis
4. The Link Between Rheumatoid Arthritis And Heart Failure
5. Smoking during pregnancy increases risk of Rheumatoid Arthritis.
6. Good News For Those Of You Suffering From Rheumatoid Arthritis
7. Mineral Oil exposure increases risk of Rheumatoid Arthritis
8. Mineral Oil exposure increases risk of Rheumatoid Arthritis
9. Novel drug holds promise for treatment of Rheumatoid Arthritis
10. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
11. Protein Linked To Accelerating Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Rheumatoid Arthritis Treatment

(Date:12/14/2009)... gardening replaced tube watching , , MONDAY, Dec. 14 (HealthDay ... hours of television a week until he enrolled in ... time in half. , During his enforced period of ... not necessarily through strenuous exercise, although he did find ... time was spent reading and working on the computer, ...
(Date:12/14/2009)... Steve Pasierb, President ,, NEW YORK, Dec. ... Monitoring the Future study (MTF) -- the largest survey ... and 12th graders -- underscores that teens, intentional abuse ... be a cause for concern, with an alarming number ... and relatives. ,, Teen Abuse of ...
(Date:12/14/2009)... Krause, an aerospace engineer,for NASA, was giving the ... he,was confident that technology and science could solve ... one thing that science couldn,t solve.,His wife Susan ... machines,would keep her alive for awhile, she would ... 69 and is starting dialysis next month. She ...
(Date:12/14/2009)... team of scientists from the UC San Diego School ... a protein switch that helps prevent liver damage, including ... better understanding of how the protein, TAK1, works could ... disease and cancer. , "TAK1 appears to be ... Brenner, MD, professor of medicine and Dean of the ...
(Date:12/14/2009)... report cites lower rates for meth and smoking, ... Dec. 14 (HealthDay News) -- Fewer teenagers are ... stalled and abuse of prescription drugs remains high, ... said that newer drugs, such as the hallucinogenic ... is intended for treatment of attention-deficit hyperactivity disorder ...
Breaking Medicine News(10 mins):Health News:Cutting TV Time Burns More Calories 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4
... a songbird may appear effortless, but his elocutions are ... and maintained throughout adulthood. His tune has virtually crystallized ... motor performance of top athletes and musicians. Yet, subtle ... and humans. Now, scientists think they know why. ...
... Gillings, Bain ... Capital and TPG, ... the formation of a new investor,partnership to support the company,s continued ... and the management team.,Gillings and global private investment firms Bain Capital ...
... MASI ), the inventor of Pulse CO-Oximetry and Read-Through ... is scheduled to,present at the 26th Annual JPMorgan Healthcare ... on Monday, January 7, 2008 at 8:30 a.m. PT.,Joe ... Raad, Executive Vice,President and CFO, will be presenting., ...
... without disease progression, study found , , FRIDAY, Dec ... two drugs, Avastin (bevacizumab) plus interferon, extends the ... report. , "Based on the result of earlier ... bevacizumab as a new drug for treating kidney ...
... Mass., Dec. 21 PLC Systems Inc.,(Amex: PLC ... Mark Certificate,for its RenalGuard System(TM), clearing the way for ... in the European Union. The Company,expects to initiate a ... in Italy, targeting early adoptors who recognize the benefits ...
... of Time" a Valuable Present: Peake, WASHINGTON, Dec. ... the volunteers who remember our nation,s,veterans, especially those hospitalized ... year., "Some of our patients will be unable ... James B. Peake, Secretary of Veterans Affairs. "The,good cheer ...
Other Medicine News:Health News:Songbirds offer clues to highly practiced motor skills in humans 2Health News:Songbirds offer clues to highly practiced motor skills in humans 3Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 2Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 3Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 4Health News:Masimo to Present at 26th Annual JPMorgan Healthcare Conference 2Health News:New Combo Treatment Extends Kidney Cancer Survival 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 3Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 4Health News:VA Salutes Volunteers' Spreading Holiday Cheer 2
(Date:12/14/2009)... -- Cancer patients in Finland have gained access ... RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: ... radiotherapy clinic in the Nordic region. Clinicians at ... and precise form of radiotherapy to treat patients ... abdomen and prostate. ,, RapidArc, which enables clinicians ...
(Date:12/14/2009)... Dec. 14 According to Millennium Research ... market intelligence, increased use of safety devices for ... be a key driver of the enteral feeding ... MRG,s new US and European Markets for ... the giving set segment will experience the greatest ...
(Date:12/14/2009)... Dec. 14 ... a leading provider of tools and services for ... that it has completed the sale of Xenogen ... pre-clinical CRO services, to Taconic Farms, Inc. for ... Caliper as part of Caliper,s acquisition of Xenogen ...
Breaking Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Ionian Technologies Inc Receives Additional Funding from the Bill 26amp 3B Melinda Gates Foundation to Develop Point of Care Diagnostic Tests for t 6373 1Ionian Technologies Inc Receives Additional Funding from the Bill 26amp 3B Melinda Gates Foundation to Develop Point of Care Diagnostic Tests for t 6373 2Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles 6369 1Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles 6369 2Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles 6369 3Covance Enters Into a Biomarker Alliance With Rules Based Medicine Inc 6365 1Covance Enters Into a Biomarker Alliance With Rules Based Medicine Inc 6365 2Covance Enters Into a Biomarker Alliance With Rules Based Medicine Inc 6365 3Covance Enters Into a Biomarker Alliance With Rules Based Medicine Inc 6365 4
... has now been studied in combination with the most ... mg, 20 mg) in patients with mixed dyslipidemiaORLANDO, Fla., ... that Abbott ,s TRILIPIX(R) (fenofibric acid) delayed-release capsules ... study,s primary endpoints. TRILIPIX 135 mg in combination ...
... A new analysis from the,JUPITER study shows that ... venous thromboembolism (VTE) by 43% (p =0.007) compared ... normal cholesterol levels and elevated,high-sensitivity C-reactive protein (hsCRP). ... American College of Cardiology Scientific Sessions (ACC) in,Orlando, ...
Other Medicine Technology:New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 2New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 3New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 4New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 5CRESTOR(R) Reduced Risk of Blood Clots in the Veins 2CRESTOR(R) Reduced Risk of Blood Clots in the Veins 3CRESTOR(R) Reduced Risk of Blood Clots in the Veins 4
The inner wall of the tube is coated with spray-dried lithium, ammonium or sodium heparin. These additives are anti-coagulants, which activate anti-thrombins, thus blocking the coagulation cascade of...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
Medicine Products: